Información del producto
Información adicional
Storage Conditions
-20°C/1 year
Applications
IHC
WB
WB
Concentration
1 mg/ml
Recomended Dilution
IHC-p 1:50-300
WB 1:500-2000
WB 1:500-2000
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human PLD4. AA range:457-506
Subcellular Location
Endoplasmic reticulum membrane
Single-pass type II membrane protein . Golgi apparatus, trans-Golgi network membrane
Single-pass type II membrane protein . Nucleus . Early endosome . Cytoplasmic vesicle, phagosome . Activation of microglia induces translocation of PLD4 from the nucleus to the phagosomes. .
Single-pass type II membrane protein . Golgi apparatus, trans-Golgi network membrane
Single-pass type II membrane protein . Nucleus . Early endosome . Cytoplasmic vesicle, phagosome . Activation of microglia induces translocation of PLD4 from the nucleus to the phagosomes. .
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Mouse
Rat
Human Gen
122618
Observed Band
50kD
Other Name
C14orf175
Choline phosphatase 4
PLD4
PLD 4
Phosphatidylcholine-hydrolyzing phospholipase D4
Phospholipase D4
Choline phosphatase 4
PLD4
PLD 4
Phosphatidylcholine-hydrolyzing phospholipase D4
Phospholipase D4
Background
catalytic activity:A phosphatidylcholine + H(2)O = choline + a phosphatidate.,similarity:Belongs to the phospholipase D family.,similarity:Contains 2 PLD phosphodiesterase domains.,